These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32797366)

  • 1. Thiopurines in Pediatric Inflammatory Bowel Disease: Current and Future Place.
    van Hoeve K; Vermeire S
    Paediatr Drugs; 2020 Oct; 22(5):449-461. PubMed ID: 32797366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD.
    Benkov K; Lu Y; Patel A; Rahhal R; Russell G; Teitelbaum J;
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):333-40. PubMed ID: 23287804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders.
    Friedman AB; Sparrow MP; Gibson PR
    Int J Rheum Dis; 2014 Feb; 17(2):132-41. PubMed ID: 24618304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease.
    Smith MA; Irving PM; Marinaki AM; Sanderson JD
    Aliment Pharmacol Ther; 2010 Jul; 32(2):119-30. PubMed ID: 20412066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimising use of thiopurines in inflammatory bowel disease.
    Dart RJ; Irving PM
    Expert Rev Clin Immunol; 2017 Sep; 13(9):877-888. PubMed ID: 28678626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and Optimization of Thiopurines and Methotrexate in Inflammatory Bowel Disease.
    Coskun M; Steenholdt C; de Boer NK; Nielsen OH
    Clin Pharmacokinet; 2016 Mar; 55(3):257-74. PubMed ID: 26255287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are we using and monitoring thiopurines and biologics optimally?
    Irving PM
    Dig Dis; 2014; 32(4):410-8. PubMed ID: 24969289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?
    Ward MG; Irving PM; Sparrow MP
    World J Gastroenterol; 2015 Oct; 21(40):11331-42. PubMed ID: 26525434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving Role of Thiopurines in Inflammatory Bowel Disease in the Era of Biologics and New Small Molecules.
    Nguyen ALH; Sparrow MP
    Dig Dis Sci; 2021 Oct; 66(10):3250-3262. PubMed ID: 33073334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do children with IBD really respond better than adults to thiopurines?
    Goodhand JR; Tshuma N; Rao A; Kotta S; Wahed M; Croft NM; Sanderson IR; Epstein J; Rampton DS
    J Pediatr Gastroenterol Nutr; 2011 Jun; 52(6):702-7. PubMed ID: 21593643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.
    Kotlyar DS; Osterman MT; Diamond RH; Porter D; Blonski WC; Wasik M; Sampat S; Mendizabal M; Lin MV; Lichtenstein GR
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):36-41.e1. PubMed ID: 20888436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.
    Johnson CM; Dassopoulos T
    Curr Gastroenterol Rep; 2018 Sep; 20(11):53. PubMed ID: 30267281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When to Start Immunomodulators in Inflammatory Bowel Disease?
    Sharara AI
    Dig Dis; 2016; 34(1-2):125-31. PubMed ID: 26982809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiopurines: Use them or lose them? International survey on current and future use of thiopurines in inflammatory bowel disease.
    Sousa P; Ministro P; Armuzzi A; Dignass A; Høivik ML; Barreiro-de Acosta M; Vavricka S; Saad-Hossne R; Kotze PG; Peyrin-Biroulet L; Magro F
    Dig Liver Dis; 2021 Dec; 53(12):1571-1579. PubMed ID: 34187768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.
    van Asseldonk DP; Sanderson J; de Boer NK; Sparrow MP; Lémann M; Ansari A; Almer SH; Florin TH; Gearry RB; Mulder CJ; Mantzaris G; van Bodegraven AA;
    Dig Liver Dis; 2011 Apr; 43(4):270-6. PubMed ID: 20934926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel disease: adherence to immunomodulators in a biological therapy era.
    Campos S; Portela F; Sousa P; Sofia C
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1313-9. PubMed ID: 27501126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
    Kanis SL; de Lima-Karagiannis A; de Boer NKH; van der Woude CJ
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1232-1241.e1. PubMed ID: 28342949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role and advances of immunomodulator therapy for inflammatory bowel disease.
    Nielsen OH; Coskun M; Steenholdt C; Rogler G
    Expert Rev Gastroenterol Hepatol; 2015 Feb; 9(2):177-89. PubMed ID: 25101818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there room for immunomodulators in ulcerative colitis?
    Chhibba T; Ma C
    Expert Opin Biol Ther; 2020 Apr; 20(4):379-390. PubMed ID: 31874578
    [No Abstract]   [Full Text] [Related]  

  • 20. Thiopurines vs methotrexate: Comparing tolerability and discontinuation rates in the treatment of inflammatory bowel disease.
    Vasudevan A; Parthasarathy N; Con D; Nicolaides S; Apostolov R; Chauhan A; Bishara M; Luber RP; Joshi N; Wan A; Rickard JA; Long T; Connoley D; Sparrow MP; Gibson PR; van Langenberg DR
    Aliment Pharmacol Ther; 2020 Oct; 52(7):1174-1184. PubMed ID: 32794599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.